Cargando…
Direct oral anticoagulants in sickle cell disease: a systematic review and meta-analysis
Autores principales: | Rozi, Waail, Rahhal, Alaa, Ali, Elrazi A., Al-Mashdali, Abdulrahman, Hilan, Yousef, Khamees, Ibrahim, Fernyhough, Liam J., Yassin, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631619/ https://www.ncbi.nlm.nih.gov/pubmed/35728061 http://dx.doi.org/10.1182/bloodadvances.2022007308 |
Ejemplares similares
-
Use of rivaroxaban in sickle cell disease and venous thromboembolism: A case report
por: Rozi, Waail, et al.
Publicado: (2021) -
Pediatric Philadelphia-Negative Myeloproliferative Neoplasms in the Era of WHO Classification: A Systematic Review
por: Al-Mashdali, Abdulrahman F., et al.
Publicado: (2023) -
Acute chest syndrome in sickle cell disease/HBE patient, A case report
por: Khamees, Ibrahim, et al.
Publicado: (2021) -
SARS-CoV-2 Omicron Variant in Patients With Chronic Lymphocytic Leukemia: Case Series
por: Khamees, Ibrahim, et al.
Publicado: (2022) -
Clinical image report of acute Cholangitis in Beta‐thalassemia major
por: Rozi, Waail, et al.
Publicado: (2022)